Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Correlations between biomarkers are demonstrated in Tables 3 and 4.Spearman’s rank correlation coefficient between biomarkers I25-OHD (nmol/l)CRP (mg-dl)ESR (mm/h)Leucocytes (103/μl)SA-A (mg/l)NT-proBNP (pg/ml)25-OHD (nmol/l)1.00CRP (mg/dl)0.081.00ESR (mm/h)0.150.341.00Leucocytes (103/μl)0.150.180.071.00SA-A (mg/l)0.17 0.512** 0.22 0.593** 1.00NT-proBNP (pg/ml)0.060.14−0.080.040.101.00Troponin I (ng/ml)0.000.120.100.180.11 0.493** HbAlc (%)−0.010.28 0.415* 0.180.110 07Hb (g/dl)−0.28−0.25 −0.360* 0.02−0.10−0.05Hc (%) −0.355* −0.19 −0.353* 0.06−0.12−0.04Creatinine (mg/dl)−0.26−0.070.110.040.00 0.355* TSH (mU/l)−0.060.290.200.050.04 0.316* *p = 0.05; **p = 0.01 25-OHD 25-OH-cholecalciferol, CRP C-reactive protein, ESR erythrocyte sedimentation rate, SA-A serum amyloid-A, NT-proBNP N-terminal pro-brain natriuretic peptide, HbAlc glycosylated haemoglobin, Hb haemoglobin, Hc haematocrit, TSH thyroid-stimulating hormoneHighlighted in bold: p ≤ 0.05 Spearman’s rank correlation coefficient between biomarkers IITroponin I (ng/ml)HbAlc (%)Hb (g/dl)Hc (%)Creatinine (mg/dl)TSH (mU/l)Troponin I (ng/ml)1.00HbAlc (%)0.221.00Hb (g/dl)0.120.241.00Hc (%)0.190.27 0.946* 1.00Creatinine (mg/dl) 0.432* 0.250.070.131.00TSH (mU/l)−0.010.08−0.19−0.200.061.00Notes: *p = 0.01 HbAlc glycosylated haemoglobin, Hb haemoglobin, Hc haematocrit, TSH thyroid-stimulating hormoneHighlighted in bold: p ≤ 0.05
Source: Biomarkers. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Patients were followed-up for 36 months.
Source: Abstract.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Mental health, serum biomarkers and survival in severe COPD: a pilot study
Study design awaiting verification · Multidisciplinary Respiratory Medicine · 2016
Original publication title
Mental health, serum biomarkers and survival in severe COPD: a pilot study
© Zilz et al. 2016
Original publication · Publisher record · CC BY 4.0 · CC0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Chronic obstructive pulmonary disease (COPD) impairs physical status and impacts on mental health. This prospective study was designed to assess associations between mental health and systemic biomarkers, and their combined relationship with long-term survival in stable severe COPD.
Source: BackgroundAbstract: What methods does the paper describe?
Forty-five patients with severe but stable COPD (forced expiratory volume in 1 s of 29.8 (quartiles: 22.6; 41.4) %predicted) were assessed using the Hospital Anxiety and Depression Scale (HADS), the Patient Health Questionnaire (PHQ), St. George’s Respiratory Questionnaire and the State-Trait Anxiety Inventory (STAI). The following serum biomarkers were measured: 25-OH-cholecalciferol, C-reactive protein, erythrocyte sedimentation rate, leucocyte number, serum amyloid-A (SA-A), N-terminal pro-brain natriuretic peptide, troponin I, glycosylated haemoglobin, haemoglobin (Hb), haematocrit (Hc), creatinine and thyroid-stimulating hormone. Patients were followed-up for 36 months.
Associations between aspects of mental health and biomarkers, and their utility as predictors of 3-year survival were evaluated by regression analyses.
Source: MethodsAbstract: Results
The prevalence of anxiety (HADS-A: 89.9 %), depression (HADS-D: 58.8 %; PHQ: 60.6 %), somatisation (PHQ-15: 81.8 %) and psychosocial stress (PHQ-stress: 60.6 %) was high. There was a significant positive association between the leucocyte count and SA-A level with STAI-trait anxiety (p = 0.03 and p = 0.005, respectively), and between leucocytes and PHQ-stress (p = 0.043). Hb and Hc were significantly negatively associated with HADS-depression (p = 0.041 and p = 0.031, respectively). Univariate Cox regression analyses revealed that leucocyte count (hazard ratio (HR) 2.976, 95 % CI 1.059-8.358; p = 0.038), and stress (HR 4.922, 95 % CI 1.06 to 22.848; p = 0.042) were linked to long-term survival.
In multivariate Cox regression analyses, including known risk factors for survival in COPD, PHQ-stress (HR 45.63, 95 % CI 1.72 to 1,208.48; p = 0.022) remained significantly associated with survival.
Source: ResultsAbstract: Conclusion
In this pilot study different dimensions of mental health were correlated to serum biomarkers, probably reflecting systemic effects of COPD. While leucocyte number and PHQ-stress were associated with long-term survival in univariate analyses, PHQ-stress remained in multivariate analyses as independent prognostic factor.
Source: ConclusionAuthors’ abstract
Background
Chronic obstructive pulmonary disease (COPD) impairs physical status and impacts on mental health. This prospective study was designed to assess associations between mental health and systemic biomarkers, and their combined relationship with long-term survival in stable severe COPD.
Methods
Forty-five patients with severe but stable COPD (forced expiratory volume in 1 s of 29.8 (quartiles: 22.6; 41.4) %predicted) were assessed using the Hospital Anxiety and Depression Scale (HADS), the Patient Health Questionnaire (PHQ), St. George’s Respiratory Questionnaire and the State-Trait Anxiety Inventory (STAI). The following serum biomarkers were measured: 25-OH-cholecalciferol, C-reactive protein, erythrocyte sedimentation rate, leucocyte number, serum amyloid-A (SA-A), N-terminal pro-brain natriuretic peptide, troponin I, glycosylated haemoglobin, haemoglobin (Hb), haematocrit (Hc), creatinine and thyroid-stimulating hormone. Patients were followed-up for 36 months.
Associations between aspects of mental health and biomarkers, and their utility as predictors of 3-year survival were evaluated by regression analyses.
Results
The prevalence of anxiety (HADS-A: 89.9 %), depression (HADS-D: 58.8 %; PHQ: 60.6 %), somatisation (PHQ-15: 81.8 %) and psychosocial stress (PHQ-stress: 60.6 %) was high. There was a significant positive association between the leucocyte count and SA-A level with STAI-trait anxiety (p = 0.03 and p = 0.005, respectively), and between leucocytes and PHQ-stress (p = 0.043). Hb and Hc were significantly negatively associated with HADS-depression (p = 0.041 and p = 0.031, respectively). Univariate Cox regression analyses revealed that leucocyte count (hazard ratio (HR) 2.976, 95 % CI 1.059-8.358; p = 0.038), and stress (HR 4.922, 95 % CI 1.06 to 22.848; p = 0.042) were linked to long-term survival.
In multivariate Cox regression analyses, including known risk factors for survival in COPD, PHQ-stress (HR 45.63, 95 % CI 1.72 to 1,208.48; p = 0.022) remained significantly associated with survival.
Conclusion
In this pilot study different dimensions of mental health were correlated to serum biomarkers, probably reflecting systemic effects of COPD. While leucocyte number and PHQ-stress were associated with long-term survival in univariate analyses, PHQ-stress remained in multivariate analyses as independent prognostic factor.
Publication and source details
Original title: Mental health, serum biomarkers and survival in severe COPD: a pilot study
Christian Zilz; Stefan H. Blaas; Michael Pfeifer; Rudolf A. Jörres; Stephan Budweiser
Multidisciplinary Respiratory Medicine · 2016
© Zilz et al. 2016https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-12T09:51:05.820849+00:00
DOI: 10.1186/s40248-016-0041-8 · PMC4717533